Andrew Saik has an estimated net worth of $3.64 Million. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., Menlo Therapeutics Inc., PDS Biotechnology Corp, AUXILIUM PHARMACEUTICALS INC, ARVINAS, INC., and Milestone Pharmaceuticals Inc..

2025 was Andrew Saik's most active year for acquiring shares with 5 total transactions. Andrew Saik's most active month to acquire stocks was the month of May. 2023 was Andrew Saik's most active year for disposing of shares, totalling 8 transactions. Andrew Saik's most active month to dispose stocks was the month of October. 2020 saw Andrew Saik paying a total of $49,920.00 for 38,400 shares, this is the most they've acquired in one year. In 2015 Andrew Saik cashed out on 175,000 shares for a total of $6,392,750.00, their largest year based on trade value.